Investing
All year long, we’ve been waiting for our favorite high-yield investments, 8%+ yielding closed-end funds (CEFs), to jump, along with the rest of the...
Hi, what are you looking for?
Repay Down
Investing
Cisco Systems Inc. gave some more details on the timing of revenue from its anticipated orders related to artificial intelligence, and it looks like...
Investing
Long-term investors have been well served by index funds, which often charge very low fees and can be hard for active portfolio managers to...
Investing
If you see a headline that a company beat analysts’ expectations when reporting its quarterly results, it may not mean very much. The analysts...
Investing
U.S.-listed shares of Nio Inc. were falling more than 5% in after-hours action Monday after the Chinese electric-vehicle company announced a convertible-bond offering. The...
Investing
It’s no secret that governments and regulators have been ramping up enforcement of greenhouse-gas regulation. But here’s something counterintuitive: Shares of some oil and...
Investing
Oil futures marked fresh highs for the year on Monday, after posting a third consecutive weekly climb on continued concerns over tightening crude supplies....
Investing
Gold prices settled Monday at their highest in more than two weeks, finding some support from weakness in the U.S. dollar ahead of a...
Investing
By Christian Moess Laursen Kingfisher is scheduled to report results for the first half of its fiscal year on Tuesday. Here is what you...
Investing
By Ian Walker Shares of Corcel rose as much as 25% on Monday after the company said that it has agreed to a convertible...
Investing
By Will Feuer Veradigm said it needs more time to complete its audit after the company, which provides healthcare information-technology services, detected internal control...
Investing
By Chris Wack Nexstar Media Group and DirecTV have officially reached a comprehensive, new multiyear distribution agreement covering 176 Nexstar-owned local television stations and...
Investing
By Colin Kellaher A second late-stage study of AbbVie’s antiwrinkle treatment Botox has met its key goals in platysma prominence, a part of the...
